ASTH ASTRANA HEALTH INC revenue, earnings and financials

For the quarter ended June 30, 2026, ASTRANA HEALTH INC reported revenue of $973M (up 48.5% from a year earlier), net income of $19.7M and diluted EPS of $0.40; over the last four quarters revenue was $3.84B and net income $42.1M; for the fiscal year ended December 2025 revenue was $3.18B, up 56.4% on the year before.

ASTH annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $3.18B, gross profit n/a, operating income $78.5M, net income $24.0M (margin 0.8%), EPS $0.46
• Fiscal year ended Dec 2024: revenue $2.03B, gross profit n/a, operating income $89.4M, net income $50.0M (margin 2.5%), EPS $0.90
• Fiscal year ended Dec 2023: revenue $1.39B, gross profit n/a, operating income $84.6M, net income $58.0M (margin 4.2%), EPS $1.29
• Fiscal year ended Dec 2022: revenue $1.14B, gross profit n/a, operating income $104M, net income $46.0M (margin 4.0%), EPS $0.99
• Fiscal year ended Dec 2021: revenue $774M, gross profit n/a, operating income $98.2M, net income $46.0M (margin 5.9%), EPS $1.52

ASTH quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $973M (up 48.5% year over year), net income $19.7M, EPS $0.40
• Quarter ended Mar 31, 2026: revenue $965M (up 55.6% year over year), net income $14.4M, EPS $0.29
• Quarter ended Dec 31, 2025 (from the annual report): revenue $951M (up 42.9% year over year), net income $7.51M, EPS $0.12
• Quarter ended Sep 30, 2025: revenue $956M (up 99.7% year over year), net income $373K, EPS $0.01
• Quarter ended Jun 30, 2025: revenue $655M (up 34.7% year over year), net income $9.42M, EPS $0.19
• Quarter ended Mar 31, 2025: revenue $620M (up 53.4% year over year), net income $6.69M, EPS $0.14
• Quarter ended Dec 31, 2024 (from the annual report): revenue $665M (up 88.4% year over year), net income −$100K, EPS −$0.14
• Quarter ended Sep 30, 2024: revenue $479M (up 37.5% year over year), net income $16.1M, EPS $0.33
• Quarter ended Jun 30, 2024: revenue $486M (up 39.6% year over year), net income $19.2M, EPS $0.40
• Quarter ended Mar 31, 2024: revenue $404M (up 19.9% year over year), net income $14.8M, EPS $0.31
• Quarter ended Dec 31, 2023 (from the annual report): revenue $353M (up 20.0% year over year), net income $9.64M, EPS $0.26
• Quarter ended Sep 30, 2023: revenue $348M (up 9.8% year over year), net income $22.1M, EPS $0.47
• Quarter ended Jun 30, 2023: revenue $348M (up 29.1% year over year), net income $13.2M, EPS $0.28
• Quarter ended Mar 31, 2023: revenue $337M (up 28.1% year over year), net income $13.1M, EPS $0.28
• Quarter ended Dec 31, 2022: revenue $294M (up 50.8% year over year), net income −$3.73M, EPS −$0.08
• Quarter ended Sep 30, 2022: revenue $317M (up 39.6% year over year), net income $23.2M, EPS $0.50
• Quarter ended Jun 30, 2022: revenue $270M (up 53.6% year over year), net income $12.0M, EPS $0.26
• Quarter ended Mar 31, 2022: revenue $263M (up 49.5% year over year), net income $13.8M, EPS $0.30
• Quarter ended Dec 31, 2021: revenue $195M, net income $12.3M, EPS $0.27
• Quarter ended Sep 30, 2021: revenue $227M, net income $34.4M, EPS $0.74

ASTH cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $115M, share buybacks $25.6M
• Fiscal year ended Dec 2024: operating cash flow $52.2M, share buybacks $900K
• Fiscal year ended Dec 2023: operating cash flow $68.2M, share buybacks $10.2M
• Fiscal year ended Dec 2022: operating cash flow $82.1M, share buybacks $9.25M
• Fiscal year ended Dec 2021: operating cash flow $70.3M, share buybacks $5.74M

ASTH balance sheet

• Jun 30, 2026: cash $401M, total assets $2.28B, total liabilities $1.68B, shareholders' equity $830M, long-term debt $883M
• Mar 31, 2026: cash $478M, total assets $2.36B, total liabilities $1.78B, shareholders' equity $800M, long-term debt $980M
• Dec 31, 2025: cash $429M, total assets $2.22B, total liabilities $1.66B, shareholders' equity $779M, long-term debt $991M
• Sep 30, 2025: cash $462M, total assets $2.24B, total liabilities $1.68B, shareholders' equity $776M, long-term debt $1.00B
• Jun 30, 2025: cash $340M, total assets $1.44B, total liabilities $904M, shareholders' equity $765M, long-term debt $401M
• Mar 31, 2025: cash $259M, total assets $1.33B, total liabilities $814M, shareholders' equity $745M, long-term debt $404M
• Dec 31, 2024: cash $288M, total assets $1.35B, total liabilities $841M, shareholders' equity $713M, long-term debt $425M
• Sep 30, 2024: cash $348M, total assets $1.29B, total liabilities $778M, shareholders' equity $705M, long-term debt $423M

What is ASTH's revenue?

ASTRANA HEALTH INC reported $3.84B of revenue over its last four quarters, through June 30, 2026.

Is ASTH profitable?

Yes. ASTRANA HEALTH INC earned $42.1M over the last four quarters.

What is ASTH's EPS?

Diluted earnings per share over the last four quarters were $0.82; $0.40 in the latest quarter.

ASTH ownership and insider trades · All stocks